Background: Studies have shown that chronic stress or UV radiation independently suppress immunity. Given their increasing prevalence, it is important to understand whether and how chronic stress and UV radiation may act together to increase susceptibility to disease. Therefore, we investigated potential mediators of a stress-induced increase in emergence and progression of UV-induced squamous cell carcinoma. Methods: SKH1 mice susceptible to UV-induced tumors were unexposed (naïve, n = 4) or exposed ( n = 16) to 2240 J/m 2 of UVB radiation three times a week for 10 weeks. Half of the UVB-exposed mice were left nonstressed (i.e., they remained in their home cages) and the other half were chronically stressed (i.e., restrained during weeks 4 -6). UV-induced tumors were measured weekly from week 11 through week 34, blood was collected at week 34, and tissues were collected at week 35. mRNA expression of interleukin (IL)-12p40, interferon (IFN)-γ , IL-4, IL-10, CD3 ε , and CCL27/CTACK, the skin T cell -homing chemokine, in dorsal skin was quantifi ed using real-time polymerase chain reaction. CD4 + , CD8 + , and CD25 + leukocytes were counted using immunohistochemistry and fl ow cytometry. All statistical tests were twosided. 
Stress and sunlight and are two factors that affect many people's daily lives. Both can be benefi cial in moderation, but longterm exposure to either can be detrimental in that both may contribute to the development and/or exacerbation of disease. It is estimated that over 2 -3 million new cases of nonmelanoma skin cancer occur each year ( 1 ) . Because of a host of psychosociopolitical factors, stress has become an increasing and inevitable part of people's lives. Chronic stress has been shown to dysregulate immune function ( 2 ) and is thought to play a role in the etiology of many diseases. Given the increasing prevalence of exposure to chronic stress and UV radiation and their ability to independently induce pathologic effects, it becomes important to understand whether and how these factors may act together to increase susceptibility to disease.
Stress is defi ned as a constellation of events -a stimulus (stressor) that precipitates a reaction in the brain (stress perception) and activates physiologic fi ght/fl ight systems in the body (stress response) ( 3 , 4 ) . Chronic stress, defi ned as stress that persists for several hours a day for weeks, months, or years ( 3 , 4 ) , has been shown to have immunosuppressive effects ( 2 ) that include suppression of skin cell -mediated immunity ( 3 ) .
The UVB component of sunlight is a complete carcinogen and is responsible for most nonmelanoma skin cancers ( 5 ) . Immediate effects of UVB radiation include DNA damage, epidermal hyperplasia, and infl ammation ( 6 ) . UVB also suppresses lymphocyte traffi cking, T cells, natural killer cell function ( 7 ) , and immune responses that are directed against squamous cell carcinoma ( 8 , 9 ) .
Here we test the hypothesis that chronic stress accelerates the emergence and progression of UVB-induced squamous cell carcinoma and inhibits its regression. We examined the effects of moderate chronic stress on the emergence, progression, and regression of squamous cell carcinoma induced by low-level (minimal erythemal dose [MED] , i.e., without blistering) exposure to UVB radiation in a mouse model. Our goal was to identify potential molecular and cellular immunologic mediators of the exacerbating effects of chronic stress on the emergence and progression of squamous cell carcinoma. Because both squamous cell carcinoma and basal cell carcinoma are immunogenic nonmelanoma skin cancers, our fi ndings may also be applicable to basal cell carcinoma, which is the most common form of skin cancer in the United States ( 10 ) .
International) animal facilities of The Ohio State University. SKH1 hairless mice are widely used in studies involving UVB exposure and skin cancer, and UVB-induced lesions in this strain resemble human squamous cell carcinoma ( 11 -13 ) . Experiments were conducted according to the protocol approved by the Institutional Laboratory Animal Care and Use Committee. The animal room was maintained on a 12-hour light -dark cycle (lights on at 6 AM ). Mice were given food and water ad libitum.
Experimental Design
Data presented here are from a single experiment. Similar results were reproduced in two additional independent experiments (data not shown). The nonstressed control group remained in their home cages whereas the chronically stressed group ( n = 8 mice per group) was moved to restraining cages. Chronic stress was administered during weeks 4 -6 of 10 weeks of UVB exposure. Both the nonstressed and chronic stress groups were exposed to UVB as described below. The " naive " control group ( n = 4) was not exposed either to stress or to UVB. Mice were monitored for tumor development (number and size) from weeks 11 through 34. Naïve control animals did not develop tumors at any point during the study. At week 35 mice were killed by CO 2 euthanasia. Tissues were dissected and stored at − 70 °C.
UVB Radiation
Mice were irradiated three times per week (on Monday, Wednesday, and Friday) for 10 consecutive weeks. Mice were placed in plastic cages during each irradiation session that were rotated between sessions with respect to their location under the light banks to ensure homogeneous UVB distribution. Mice were exposed to UVB from sunlamps (American Ultraviolet Company, Murray Hill, NJ) fi tted with Kodacel fi lters (Eastman Kodak, Rochester, NY) that allow UVB light to pass through (290 -320 nm). A UVB dose of 2240 J/m 2 (MED, approximately a 10-minute exposure), as measured by a UVX digital radiometer (UVP, Inc., San Gabriel, CA), was administered. This MED was previously determined and was recently validated by T.M.O. (unpublished data).
Stress Exposure
Mice were stressed 6 hours per day for 21 days during weeks 4 -6 of UVB exposure. On days of UV exposure, the stress session preceded UV exposure. Stress was administered by placing each mouse in an adequately ventilated restrainer while ensuring that the mouse was not squeezed or compressed. This procedure mimics stress that is largely psychological in nature because of the perception of confi nement experienced by the mice ( 14 , 15 ) . It activates the sympathetic nervous system ( 16 ) and the hypothalamic-pituitary-adrenal axis ( 17 , 18 ) and results in the activation of adrenal steroid receptors in tissues throughout the body ( 17 , 18 ) . Importantly, as shown later, this model of moderate chronic stress does not decrease body, spleen, or thymus weight and does not impair the overall health of the mice.
Blood Collection for Corticosterone Analysis
Blood was collected (at approximately 9:00 AM ) during week 34. Mice were lightly anesthetized using isofl urane, and approximately 60 μ L of blood was collected from the retro-orbital sinus into heparinized tubes. Plasma aliquots were obtained immediately and stored at − 70 °C.
Corticosterone Radioimmunoassay
Plasma corticosterone was determined using the ImmuChem Double Antibody Corticosterone I 125 RIA Kit (MP Biomedicals, Inc., Costa Mesa, CA) according to the manufacturer's instructions. Samples were counted on a Packard Cobra II Gamma Counter (Packard Instrument Co., Meridian, CT). All corticosterone values are reported in μg/100 m L of plasma.
Tumor Counts and Measurements
None of the mice had tumors at baseline. Beginning at week 11, mice were monitored for tumor development. No tumors were observed for naïve (no UV exposure and no chronic stress) mice at any time point during the study. Moreover, in our previous experience, we have not observed skin tumors in mice that have only been chronically stressed in the absence of UVB exposure. Any tumor that was observed in the UVB-exposed nonstressed and chronically stressed mice was defi ned as a mass having a diameter of at least 1 mm. Tumors were counted and measured weekly. The two longest measurements (mm) in perpendicular directions were made using a Cen-Tech digital caliper (Harbor Freight Tools, Camarillo, CA) and were multiplied to obtain a representation of tumor area (expressed in mm 2 ). Tumor regression was measured as the percent change in tumor number at week 34 relative to week 33. A negative percentage indicates no tumor regression and an increase in tumor number. A positive percentage indicates regression of tumors from the previous week.
Tumor Histology
Tumors were excised, placed in 10% neutral-buffered formalin for 2 hours, washed in phosphate-buffered saline, processed, and embedded in paraffi n blocks. Sections (5 μ m) were mounted onto Superfrost Plus microscope slides (Fisher Scientifi c, Pittsburgh, PA) and stained with hematoxylin and eosin, and histopathologic examination was performed on the largest tumor from each mouse (diameter >3 mm). Tumors were classifi ed as papilloma, microinvasive squamous cell carcinoma, or invasive squamous cell carcinoma by a veterinary pathologist (D.K.).
Measurement of Gene Expression
Gene expression of naive mice was measured in normal dorsal skin because these mice had not been exposed to stress or UVB. Gene expression for the UVB-treated groups (nonstressed and chronic stress) was measured in dorsal skin that included thickened areas of epidermis-containing lesions (diameter <2 mm) that represent a transition from focal epidermal hyperplasia to true papilloma and are part of the spectrum of lesions leading ultimately to squamous cell carcinoma ( 19 -21 ) . Total RNA from frozen dorsal skin was extracted by homogenization in Trizol (Invitrogen, Carlsbad, CA). One sample was analyzed from each mouse in each treatment group. Absorbance measurements at 260 and 280 nm were used to determine the concentration and purity of the RNA. mRNA was then isolated from 20 μ g of total RNA from each sample using Dynabeads oligo(dT) 25 (Dynal Biotech, Lake Success, NY). Reverse transcription of the mRNA was carried out at 42 °C for 60 minutes, 90 °C for 5 minutes in a total volume of 25 μ L using AMV Reverse Transcriptase Reaction Buffer (Promega, Madison, WI), 1 m M concentrations of each dNTP (Invitrogen), 25 U of RNase Inhibitor (Roche Applied Science, Indianapolis, IN), 0.6 μ g of oligo(dT) 12 -18 primer (Invitrogen), and 15 U of any reverse transcriptase (Promega).
Sequences from GenBank and the Primer Express 1.5a software (Applied Biosystems, Foster City, CA) were used to design primers and probes. If possible, either the probe or one of the primers was placed over an intron -exon junction to avoid amplifi cation of contaminating genomic DNA. Probes were labeled at the 5 ′ end with FAM and at the 3 ′ end with TAMRA (Biosearch Technologies, Novato, CA). Primers were synthesized by Invitrogen. TaqMan Rodent glyceraldehyde-3-phosphate dehydrogenase (GADPH) Control Reagents were obtained from Applied Biosystems. The ABI Prism 7500 Sequence Detection System (Applied Biosystems) was used to quantify gene expression. For each gene measurement, 3 μ L of cDNA diluted 1 : 15 were used in a fi nal volume of 25 μ L containing TaqMan Universal polymerase chain reaction (PCR) Master Mix (Applied Biosystems), gene-specifi c primers and probe, and TaqMan Rodent GAPDH Control Reagents. Thermal cycling parameters were 50 °C for 2 minutes (activation of AmpErase uracil-Nglycosylase, 95 °C for 10 minutes (activation of AmpliTaq Gold DNA Polymerase) and 40 cycles of 95 °C for 15 seconds (melt) and 60 °C for 1 minute (anneal/extend). Threshold cycles (C T values) were determined using the 7500 Sequence Detection Software (Applied Biosystems). Real-time PCR results were normalized across samples using GAPDH as an internal standard. Δ C T values were calculated for each sample by subtracting the GAPDH C T value from the cytokine or chemokine C T value. Δ C T values were converted from exponential to linear by using the formula 2 − ( Δ C T ) .
Immunohistochemistry
Leukocyte subtypes were analyzed in dorsal skin that included thickened areas of epidermis containing lesions (diameter <2 mm) that represent a transition from focal epidermal hyperplasia to true papilloma and are part of the spectrum of lesions leading ultimately to squamous cell carcinoma. Skin samples were embedded in TBS Tissue Freezing Medium (Triangle Biomedical Sciences, Durham, NC), sectioned (10 μ m), and mounted on Superfrost Plus microscope slides (Fisher Scientifi c). Sections were quenched for endogenous peroxidase, blocked in 10% normal goat serum, and incubated with primary antibodies (BD PharMingen, San Diego, CA), rat anti-mouse CD4 (1 : 25), rat antimouse CD8 (1 : 50), or biotin rat anti-mouse CD25 (1 : 25), biotin blocked for 40 min (Biotin Blocking System, Dako, Carpinteria, CA), and incubated with mouse-adsorbed bio tinylated rabbit anti-rat immunoglobulin (1 : 200) (Vector, Burlingame, CA). 3,3-Diaminobenzidine-tetrahydrochloride (Dako) was used as substrate chromogen and hematoxylin as counterstain. Murine spleen tissue was used as a positive control, and no primary antibody was the negative control. The number of positive cells per standardized fi eld (16 085 μ m 2 ) were counted by an observer who was blinded to the treatment groups. Ten fi elds at ×60 magnifi cation were analyzed per skin section; n = 5 mice per treatment group.
Detection of T Regulatory Cells (CD4 + CD25 + ) in Peripheral Blood
Numbers of regulatory/suppressor T cells (i.e., CD4 + and CD25 + cells) were measured in peripheral blood using fl ow cytometry (FACSCalibur, Becton Dickinson, San Jose, CA). Directly conjugated rat anti-mouse allophycocyanin-labeled anti-CD4 and phycoerythrin-labeled anti-CD25 (BD PharMingen) antibodies were used to double-label cells. Leukocytes were stained and analyzed as described previously ( 22 ) .
Statistical Analysis
Data are expressed as means and 95% confi dence intervals (CIs). Nonparametric Wilcoxon rank sum tests were used for all group comparisons (with nonmodel outcomes) at the primary endpoints (week 34 or week 35). To estimate both the changes in tumor counts as well as in tumor size over time (weeks 11 -34), separate linear mixed-effects models were applied. The KaplanMeier estimates of the survival function in both treatment groups were calculated, and the log-rank test was used to assess differences between the groups. Fisher's exact test was used to test for differences in tumor stages between the treatment groups. To compare the differences in body weights over time, a repeatedmeasures analysis of variance was used. P <.05 was considered as statistically signifi cant. All statistical analyses were twosided and were performed using SAS version 9.1 (SAS Institute, Cary, NC).
R ESULTS

Effects of Chronic Stress on Tumor Emergence, Progression, and Regression
Using the linear mixed-effects model, we found that the estimated weekly increase in the number of tumors was higher in the chronically stressed mice than in the nonstressed mice (0.5 tumor/wk versus 0.2 tumor/wk; difference = 0.3 tumor/wk, 95% CI = 0.03 to 0.49; P = .02) ( Table 1 ). From this model we also estimated that, at week 34, the stressed mice had more tumors on average than the nonstressed mice (84 tumors versus 32 tumors, difference = 52 tumors, 95% CI = 0.9 to 10.3; P = .02). Using a longitudinal model fi t to the data, we found that there were no statistically signifi cant differences in tumor size over time between the groups ( Table 1 ) . Kaplan -Meier estimates of the survival function indicate that the median time to the fi rst tumor was shorter in the chronically stressed group compared with that in the nonstressed group (15 weeks versus 16.5 weeks, difference = 1.5 weeks, 95% CI = − 3.0 to 3.3; P = .03) ( Table 1 ) . The stressed group also reached 50% (15 weeks versus 21 weeks) and 100% (31 weeks versus 34 weeks) tumor incidence earlier than the nonstressed group ( Table 1 ) . Furthermore, by week 34 the nonstressed group showed 30% tumor regression and no new tumors compared with the previous week ( Table 1 ). In contrast, the stressed group did not show any tumor regression from the previous week, but instead showed a 16% increase in tumor numbers ( P = .02).
Chronic stress accelerated tumor emergence, enhanced tumor progression, and suppressed tumor regression. The largest tumor (diameter >3 mm) from each mouse was histologically classifi ed as benign papilloma, microinvasive squamous cell carcinoma, or invasive squamous cell carcinoma (by D.K.). The only invasive squamous cell carcinoma was seen in a chronically stressed mouse. Most tumors were microinvasive squamous cell carcinoma (four of six tumors in nonstressed mice and fi ve of eight in stressed mice) and benign papillomas (two of six in nonstressed mice and two of eight in stressed mice).
Despite the administration of chronic stress, body weights in the two groups were similar across the entire study period ( Fig. 1 ) . Moreover, weights of spleen (nonstressed versus chronic stress, mean = 0.287 g versus 0.385 g, difference = 0.098 g), thymus (nonstressed versus chronic stress, mean = 0.036 g versus 0.044 g, difference = 0.008 g), and adrenal gland (nonstressed versus chronic stress, mean = 0.008 g versus 0.011 g, difference = 0.003 g) were also similar between the two groups. .02 § * A tumor was defi ned as a mass having a diameter of at least 1 mm. Tumors were counted and measured weekly from weeks 11 to 34. Two measurements (mm) in perpendicular directions were made using a digital caliper and were multiplied to obtain a representation of tumor area (expressed in mm 2 ). NA, not applicable.
† Total number of tumors at week 34. ‡ P value (two-sided) calculated using the linear mixed-effects model . § Estimated by linear mixed-effects model; 95% confi dence interval on the difference = 0.03 to 0.49. || Mean number of tumors per animal at week 34. ¶ P value (two-sided) calculated using the Wilcoxon rank sum test . # Mean tumor area at week 34. ** Median week to fi rst tumor, estimated by Kaplan -Meier survival analysis; 95% confi dence interval on the difference = -3.0 to 3.3.
† † P value (two-sided) calculated from log-rank test. ‡ ‡ Week at which 50% of the animals in each group expressed tumors. § § Week at which 100% of the animals in each group expressed tumors. |||| Percent decrease in tumor number at week 34 relative to week 33. A positive percentage indicates regression of tumors from the previous week. A negative percentage indicates no tumor regression and an increase in tumor number. The chronic stress group did not show regression but instead showed a 16% increase in tumor number. 
Effects of Chronic Stress and UV Exposure on the Circadian Corticosterone Rhythm
Circadian cortisol rhythm disruption has been associated with cancer progression. We measured plasma corticosterone to examine whether the chronic stress -induced increase in tumor burden was associated with circadian rhythm dysregulation. Such dysregulation would be indicated by elevated plasma corticosterone at the beginning of the inactive period of the diurnal cycle, a time of day when the lowest corticosterone levels are normally observed. Chronically stressed mice had higher but statistically non-signifi cant corticosterone levels than nonstressed controls (mean = 16.9 μ g/100 mL versus 6.45 μ g/100 mL, difference = 10.5, 95% CI = − 0.65 to 22.5; P = .09).
Effects of Chronic Stress and UV Exposure on Cytokine and Chemokine Gene Expression
Levels of gene expression for interleukin (IL)-12p40, interferon (IFN)-γ , IL-10, IL-4, cutaneous T cell -attracting chemokine [CCL27/CTACK, a chemokine that mediates T-cell homing to skin ( 20 ) ], and CD3 ε (an index of T cell infi ltration) were measured for the naive (no stress and no UVB), nonstressed, and chronically stressed groups ( Table 2 ) . For all genes examined, gene expression levels in the skin of naïve mice were lower than those in UVB-treated mice ( Table 2 ) . Among the UVB-treated mice, chronically stressed mice had statistically signifi cantly lower gene expression of IFN-γ (mean = 0.03 versus mean = 0.07, difference = 0.04, 95% CI = 0.004 to 0.073; P = .02) and lower IL-12p40 gene expression than nonstressed mice. In contrast, levels of IL-10 and IL-4 gene expression were similar. Chronically stressed mice also had considerably lower expression of CCL27/CTACK (mean = 101 versus mean = 142, difference = 41, 95% CI =8.1 to 74.4; P = .03) and CD3 ε (mean = 0.18 versus mean = 0.36, difference = 0.18, 95% CI = 0.06 to 0.30; P = .007) gene expression than nonstressed mice.
Effects of Chronic Stress on T-Cell Infi ltration
Because we observed associations between chronic stress and the expression of genes involved in stimulating protective T-cell responses, we sought to determine whether chronic stress induces a decrease in T cell infi ltration and cell-mediated immunity. To do so, we measured and compared T cell numbers in the skin of nonstressed and chronically stressed mice. Photomicrographs of representative sections and graphs of cell numbers are shown in Fig. 2 . Chronically stressed mice had considerably lower skin CD4 + T cell infi ltration (mean = 9.40 cells/fi eld versus mean = 13.7 cells/fi eld, difference = 4.3 cells/fi eld, 95% CI = 2.36 to 6.32; P = .008) compared with nonstressed mice. The number of CD8 + cells was also lower in the skin of stressed mice; however, this difference was statistically non-signifi cant. Numbers of circulating CD4 + and CD8 + T cells were similar between nonstressed and chronically stressed mice.
Effects of Chronic Stress on Regulatory/Suppressor Cells in Tumors and in Circulation
Recent clinical studies have shown that regulatory/suppressor T cells are involved in inhibiting antitumor responses and suppressing effector cell function within tumors and are associated with increased mortality ( 23 , 24 ) . Therefore, we investigated the hypothesis that chronic stress will increase susceptibility to squamous cell carcinoma by promoting or enhancing the function of immune " suppressor " mechanisms. To do so, we examined the effects of chronic stress on numbers of regulatory/suppressor cells within tumors and in peripheral blood. Photomicrographs of representative sections and cell numbers are shown in Fig. 3 . Chronically stressed mice showed greater CD25 + cell infi ltration into tumors than nonstressed mice ( Fig. 3, C ) , but the difference was not statistically signifi cant. In addition, stressed mice also had considerably higher numbers of CD4 + CD25 + T cells in the peripheral blood (mean = 0.36 versus mean = 0.17, difference = 0.19, 95% CI = 0.005 to 0.38; P = .03) ( Fig. 3, D ) .
D ISCUSSION
In this study, we demonstrated that chronic stress profoundly accelerates the emergence and development of squamous cell carcinomas and their precursors while suppressing tumor regression in a mouse model. To our knowledge, this is the fi rst study to elucidate the cellular and molecular mechanisms mediating a chronic stress-induced increase in susceptibility to skin cancer. Chronic stress administered during the middle 3 weeks of mild, nonblistering UVB exposure caused more mice to develop * In naive animals ( n = 4, no exposure to UVB or chronic stress), gene expression was measured in normal dorsal skin. Both the no stress ( n = 8) and the chronic stress groups ( n = 8) were exposed to UVB as described under " Materials and Methods. " Gene expression was measured in areas of dorsal skin that included thickened areas of epidermis containing lesions (diameter <2 mm), which represent a transition from focal epidermal hyperplasia to true papilloma and are part of the spectrum of lesions leading ultimately to squamous cell carcinoma. Levels of mRNA expression relative to glyceraldehyde-3-phosphate dehydrogenase are shown. CI = confi dence interval.
† P values (two-sided) comparing nonstressed mice with chronically stressed mice were calculated using the Wilcoxon rank sum test. tumors and to develop them faster than nonstressed mice ( Table 1 ) . These chronically stressed mice had an earlier onset of the fi rst tumor and also reached 50% and 100% incidence earlier than the nonstressed mice ( Table 1 ) . Although median time to fi rst tumor and time of 50% incidence were the same for the chronically stressed group, the 4.5-week gap between median time to fi rst tumor and time of 50% incidence in the nonstressed mice indicates greater spontaneous regression of tumors during this period in the nonstressed group. In addition, chronically stressed mice showed no tumor regression at week 34 whereas nonstressed mice did ( Table 1 ) . Our results suggest that suppressed immune function and increased tumor promotion during chronic stress exposure have long-lasting effects. Support for this fi nding also comes from studies showing that chronic stress suppresses skin cell-mediated immunity ( 3 ) and that cell-mediated immunity is critical for elimination of squamous cell carcinomas because these tumors are known to be immunogenic tumors ( 8 , 9 ) . Stress has also been shown to suppress natural killer cell activity and enhance experimental tumor metastasis after intravenous injection of a tumor cell line ( 25 , 26 ) . Parker et al. ( 27 ) have used an extended model of chronic stress that was initiated 2 weeks before and administered during a more prolonged period of UV exposure to show accelerated formation of cutaneous neoplasms. It is important to appreciate that, in the current study, chronic stress was administered for only 3 weeks during the period of UV-induced tumor promotion and yet had effects on critical molecular and cellular mediators of antitumor immunity that were observed 8 months later. This result suggests that a relatively moderate chronic stressor can be a potent immunosuppressor during critical periods of immune response development and can set the stage for suppression of antitumor immunity long after stress has ended. Stressed mice had higher basal corticosterone levels nearly 28 weeks after the cessation of stress. A salubrious corticosterone rhythm is one that shows low levels of plasma corticosterone at the beginning of the inactive period of the diurnal cycle (morning for nocturnal rodents) and higher levels at the beginning of the active period (evening) ( 28 ) . The higher morning corticosterone levels observed in the stressed group indicate dysregulation of the circadian rhythm. Circadian rhythm dysregulation may negatively affect immune function and health ( 29 ) and has been associated with increased cancer progression ( 30 -32 ) and mortality ( 33 ) . In addition, a dysregulated cortisol rhythm may induce immune dysregulation ( 28 , 34 ) and accelerate tumor growth because the host circadian clock is an important control point in tumor progression ( 31 , 32 ) . Future studies using additional sampling time points will be required to elucidate the kinetics and magnitude of circadian rhythm dysregulation during skin cancer and to determine whether the dysregulated rhythm was a cause or effect of increased tumor burden.
We used real-time PCR to quantify differences in gene expression between naïve, nonstressed, and chronically stressed animals. IL-12p40 and IFN-γ gene expression was suppressed in chronically stressed animals. IL-12 has been shown to promote Th1 responses that drive cell-mediated immunity ( 35 ) . IL-12 therapy has been shown to slow the growth of murine mammary tumors by preventing neovascularization and by increasing the number of infi ltrating leukocytes ( 36 ) and intratumoral administration of IL-12 has been shown to elicit a Th1 response profi le in sentinel lymph nodes ( 37 ) . Although measurement of IL-12p40 gene expression may not be entirely indicative of the biologically active IL-12p70 heterodimer, IL-12p40 does appear to be an important representation of IL-12 activity in vivo ( 38 , 39 ) . It has also been shown that the p19 subunit of IL-23 forms a heterodimer with the p40 subunit of IL-12 to form IL-23 ( 40 ) . Therefore, it is possible that the level of IL-12p40 gene expression may indicate IL-23 activity. Although further analyses of cytokine proteins are required to determine the exact cytokine involved, both IL-12 and IL-23 are important mediators of cellular immunity ( 41 ) , and IL-23 also promotes antitumor immunity ( 42 ) . IFN-γ promotes tumor recognition and elimination ( 43 ) , is a critical mediator of the antitumor effects of , and enables immune system suppression of tumors ( 45 ) . Therefore, stressinduced decreases in IL-12 and IFN-γ gene expression suggest suppression of critical protective immune mechanisms. In contrast, IL-4 and IL-10 gene expression was not different between groups. Based on these studies, it appears that stress-induced immunosuppression of anti -squamous cell carcinoma responses may be mediated by suppression of type 1 versus type 2 cytokines that would in turn suppress antitumor immunity.
CCL27/CTACK and CD3 ε gene expression was also suppressed in chronically stressed animals. CTACK is predominantly expressed in the skin and is critical for attracting skin-homing T cells ( 46 ) . CD3 ε gene expression can be considered an index of T-cell infi ltration. Importantly, T cells have been implicated in both the regression ( 47 ) and rejection ( 48 ) of UVinduced squamous cell carcinoma. Therefore, down-regulation of CTACK gene expression may contribute to suppression of T cell infi ltration and T cell -driven antitumor immune responses. With the exception of the effects of stress on CD3 ε gene expression (which are confi rmed by the observed effects on T cell infi ltration), we did not examine changes in protein expression for the genes measured in this study. Further studies are required to confi rm that the observed effects on gene expression translate to the level of protein expression.
Our observation that chronic stress decreased the numbers of infi ltrating CD4 and CD8 T cells around tumors further supports the hypothesis that increased susceptibility to squamous cell carcinoma may be mediated by stress-induced suppression of protective T cell -mediated immunity. Both helper and cytolytic T cell responses are likely to be important in controlling tumor growth, and T cells have been shown to mediate regression of nonmelanoma skin cancers ( 47 -49 ) . CD4 + T cells have also been found to be crucial for controlling tumor growth by cytolytic T lymphocyte -independent mechanisms ( 50 ) . Interestingly, IFN-γ , shown here to be suppressed by chronic stress, appears to be involved in CD4 + T cell-mediated elimination of tumors ( 51 ) .
Regulatory/suppressor T cells are a subset of cells expressing both CD25 (the IL-2 receptor α chain) and CD4 ( 52 ) . High levels of these cells have been detected in human cancers ( 23 , 24 ) . CD25 + T cells impair effector cell function by suppressing IFN-γ secretion ( 53 ) and may suppress antitumor immune responses ( 23 ) . Given these fi ndings, it is likely that the CD25 + cell populations that we detected in skin tumors were of the T regulatory/ suppressor subset although further studies using dual staining are required to specifi cally identify this leukocyte subset. Chronic stress increased the numbers of CD25 + cells within tumors ( Fig. 3 ) while decreasing the numbers of CD4 + and CD8 + cells around tumors ( Fig. 2 ) . It is possible that the increased number of CD25 + cells within tumors of chronically stressed animals suppressed the recruitment of protective T cells and prevented them from mounting effective antitumor immune responses. The increased numbers of CD4 + CD25 + cells in peripheral blood ( Fig. 3, D ) show that chronic stress also increased regulatory/suppressor cell numbers in the circulation. Taken together, these results suggest that regulatory/suppressor T cells play an important role in chronic stress -induced immunosuppression and increased susceptibility to squamous cell carcinoma.
The model used in this study has several potential limitations. The multifactorial nature of cancer progression and the involvement of different physiologic systems (nervous, endocrine, and immune) described here highlight the importance of conducting follow-up studies to further elucidate the molecular, cellular, and physiologic mechanisms by which chronic stress increases susceptibility to skin cancer. Additional studies quantifying changes in protein levels need to be conducted to confi rm the gene expression effects presented in the current study. The extent of the relative contribution of the individual cell types identifi ed here to the tumor development process must be determined by selective depletion or via specifi c inactivation. Moreover, additional hormone analysis time points at different stages of tumor development are required to elucidate the kinetics and magnitude of circadian rhythm dysregulation and to determine whether the dysregulated rhythm is a cause or effect of increased tumor burden. Finally, future human studies elucidating mechanisms mediating the link between stress and skin tumor development are required to confi rm and translate these fi ndings from bench to bedside.
Our data suggest that chronic stress increases susceptibility to skin cancer and shifts the balance from protective to suppressive immune responses. Chronic stress suppresses type 1 cytokines and CCL27/CTACK gene expression and suppresses CD4 + and CD8 + T cell infi ltration at sites of tumor emergence and progression while increasing the numbers of regulatory/suppressor cells at tumor sites and in circulation. These results are, to our knowledge, the fi rst to show that chronic stressors increase susceptibility to disease by mobilizing endogenous immunosuppressive mechanisms such as regulatory/suppressor T cells. Our results show that a moderate chronic stressor, one that does not have overall health-aversive effects (no change in body and organ weights), can substantially increase susceptibility to skin cancer. Moreover, the detrimental effects of stress on critical clinical, cellular, and molecular parameters are observed months after the cessation of stress.
Stress pervades almost all aspects of life and is especially salient during diagnosis, treatment, and follow-up for cancer and other diseases. Therefore, these fi ndings may be relevant for conditions in which chronic stress may increase susceptibility to other cancers, decrease effectiveness of tumor immunotherapy, or contribute to systemic immunosuppression during cancer treatment. It is hoped that knowledge gained from transdisciplinary studies such as these that examine cancer in a holistic context will increase the accuracy and timeliness of risk evaluation, improve preventative and therapeutic interventions, and help optimize a patient's response to treatment.
